5 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Active TB: • ... Treatment: Active ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Active TB: • ... Treatment: Active ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... no evidence of active ... Mycobacterium #Tuberculosis ... opportunistic #infections #HIVAIDS ... #pharmacology
TB
This patient presented first with the CXR on the left.
The findings are:
Widespread ill-defined densities, which are
TB This patient ... CXR some years later ... #Clinical #Radiology ... #CXR #Tuberculosis ... #TB #Active #SecondaryTB
Digoxin Pharmacology and Pathophysiology
1) Na/K ATPase Pump - Digoxin works by directly binding to and inhibiting
Digoxin Pharmacology ... and Pathophysiology ... Decreased heart rate ... #Pathophysiology ... #cardiology